# Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia

> **NCT00034801** · PHASE4 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 378 (—)

## Conditions studied

- Depression
- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** olanzapine
- **DRUG:** ziprasidone

## Key facts

- **NCT ID:** NCT00034801
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-09
- **Primary completion:** —
- **Final completion:** 2003-03
- **Target enrollment:** 378 (—)
- **Last updated:** 2006-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00034801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00034801, "Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00034801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*